Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
Steven E. Nissen, A. Michael Lincoff, Danielle M. Brennan, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 15, pp. 1353-1364
Closed Access | Times Cited: 509

Showing 1-25 of 509 citing articles:

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2024) Vol. 149, Iss. 8
Open Access | Times Cited: 837
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
Nikolaus Marx, Massimo Federici, Katharina Schütt, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4043-4140
Open Access | Times Cited: 651
2024 ESC Guidelines for the management of chronic coronary syndromes
Christiaan Vrints, Felicita Andreotti, Konstantinos C. Koskinas, et al.
European Heart Journal (2024) Vol. 45, Iss. 36, pp. 3415-3537
Open Access | Times Cited: 419
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S179-S218
Open Access | Times Cited: 169
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
Gerald F. Watts, Samuel S. Gidding, Robert A. Hegele, et al.
Nature Reviews Cardiology (2023) Vol. 20, Iss. 12, pp. 845-869
Open Access | Times Cited: 126
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
Lucia Mazzolai, Gisela Teixidó‐Turà, Stefano Lanzi, et al.
European Heart Journal (2024)
Open Access | Times Cited: 102
Inflammation in acute myocardial infarction: the good, the bad and the ugly
M. Matter, Francesco Paneni, Peter Libby, et al.
European Heart Journal (2023) Vol. 45, Iss. 2, pp. 89-103
Open Access | Times Cited: 95
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
Steven E. Nissen, Venu Menon, Stephen J. Nicholls, et al.
JAMA (2023) Vol. 330, Iss. 2, pp. 131-131
Open Access | Times Cited: 78
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease
Julia Brandts, Kausik K. Ray
Nature Reviews Cardiology (2023) Vol. 20, Iss. 9, pp. 600-616
Closed Access | Times Cited: 53
Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance
Paul M. Ridker, Lei Lei, Michael J. Louie, et al.
Circulation (2023) Vol. 149, Iss. 1, pp. 28-35
Open Access | Times Cited: 52
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)
Maciej Banach, Peter E. Penson, Michel Farnier, et al.
Progress in Cardiovascular Diseases (2023) Vol. 79, pp. 2-11
Open Access | Times Cited: 47
Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial
Kausik K. Ray, Stephen J. Nicholls, Na Li, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 12, Iss. 1, pp. 19-28
Open Access | Times Cited: 47
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Daniel Tobias Michaeli, Julia Caroline Michaeli, Sebastian Albers, et al.
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 5, pp. 477-495
Open Access | Times Cited: 40
World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update
Liliana Laranjo, Fernando Laņas, Marie Chan Sun, et al.
Global Heart (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 32
Atherosclerotic plaque stabilization and regression: a review of clinical evidence
Ashish Sarraju, Steven E. Nissen
Nature Reviews Cardiology (2024) Vol. 21, Iss. 7, pp. 487-497
Closed Access | Times Cited: 31
The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
Omar Mhaimeed, Zain Burney, Stacey L. Schott, et al.
American Journal of Preventive Cardiology (2024) Vol. 18, pp. 100649-100649
Open Access | Times Cited: 21
Colchicine’s Role in Cardiovascular Disease Management
Leo F. Buckley, Peter Libby
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 5, pp. 1031-1041
Closed Access | Times Cited: 21
Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography
Nick S. Nurmohamed, Alexander R. van Rosendael, Ibrahim Danad, et al.
European Heart Journal (2024) Vol. 45, Iss. 20, pp. 1783-1800
Open Access | Times Cited: 21
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S207-S238
Closed Access | Times Cited: 21
Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities
Chad Stroope, Felix Sebastian Nettersheim, Brian G. Coon, et al.
Nature Metabolism (2024) Vol. 6, Iss. 4, pp. 617-638
Open Access | Times Cited: 18
Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors
Brian Tomlinson, Qianyan Wu, Yi-ming Zhong, et al.
Journal of Lipid and Atherosclerosis (2024) Vol. 13, Iss. 1, pp. 2-2
Open Access | Times Cited: 17
High lipoprotein(a): Actionable strategies for risk assessment and mitigation
Gissette Reyes‐Soffer, Calvin Yeang, Erin D. Michos, et al.
American Journal of Preventive Cardiology (2024) Vol. 18, pp. 100651-100651
Open Access | Times Cited: 17
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Yehuda Handelsman, John E. Anderson, George L. Bakris, et al.
Metabolism (2024) Vol. 159, pp. 155931-155931
Open Access | Times Cited: 16
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Sunil V. Rao, Michelle L. O’Donoghue, Marc Ruel, et al.
Circulation (2025)
Closed Access | Times Cited: 3
American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia
Shailendra B. Patel, Kathleen Wyne, Samina Afreen, et al.
Endocrine Practice (2025) Vol. 31, Iss. 2, pp. 236-262
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top